Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Human immunodeficiency virus
89%
Malaria
30%
Infection
29%
Men Who Have Sex with Men
28%
Tuberculosis
27%
Arm
25%
Pre-Exposure Prophylaxis
25%
Diagnostic Accuracy
23%
Prevalence
22%
Visceral Leishmaniasis
21%
Sexually Transmitted Disease
21%
Antiretroviral Therapy
21%
Neisseria gonorrhoeae
16%
Post-Exposure Prophylaxis
15%
Retrospective Cohort Study
14%
Rifampicin
14%
Ethiopia
13%
Diseases
12%
Rapid Diagnostic Test
12%
Pregnant Woman
11%
Chlamydia Trachomatis
11%
Randomized Controlled Trial
11%
Public Health
11%
Informed Consent
10%
Monkeypox
10%
Ecological Analysis
10%
C Reactive Protein
9%
Virus Infection
9%
Immune Reconstitution Inflammatory Syndrome
9%
Adverse Event
8%
Ebolavirus
8%
Odds Ratio
8%
Antibiotic Resistance
8%
Prospective Cohort Study
8%
Combination Therapy
8%
Bloodstream Infection
8%
Gonorrhea
8%
Clinical Trial
7%
Diagnostic Test
7%
Mefloquine
7%
Artesunate
7%
Antiinfective Agent
7%
Oral
7%
Hansen's disease
7%
Hazard Ratio
7%
Lymphogranuloma Venereum
7%
Mixed Infection
7%
Clinical Feature
7%
Cost-Effectiveness Analysis
6%
Safe Sex
6%
Sexual Behavior
6%
Cutaneous Leishmaniasis
6%
Drug Resistant Tuberculosis
6%
Antibody Response
6%
Meta-Analysis
6%
Lifespan
6%
Clinical Decision Making
6%
Artemisinin
6%
Health Care Cost
6%
Case Definition
6%
Morbidity
6%
Rabies
5%
Rabies Immunoglobulin
5%
Tuberculosis Treatment
5%
Cohort Analysis
5%
Mixed Methods
5%
COVID-19
5%
Clinician
5%
Skin Defect
5%
Monkeypox Virus
5%
Thorax Radiography
5%
Immunology and Microbiology
Human immunodeficiency virus
100%
Infection
66%
Infectious Disease
63%
Prevalence
44%
Visceral Leishmaniasis
40%
Neisseria gonorrhoeae
20%
Malaria
16%
Blood Plasma
16%
Arm
15%
Hepatitis C
14%
Viral Disease
12%
Viral Load
12%
Antibiotic Resistance
12%
Coinfection
11%
T Cell
10%
Monkeypox
10%
Hepatitis C Virus
10%
Infectious Agent
8%
CD4 Lymphocyte Count
8%
ELISA
8%
Monkeypox Virus
8%
Immunogenicity
8%
Immunoassay
8%
Susceptibility
7%
Leishmania
7%
Epidemiology
7%
Cohort Effect
7%
Adolescence
7%
Schistosoma haematobium
7%
Leishmania donovani
7%
Rabies
6%
Chlamydia Trachomatis
6%
Immune Reconstitution Inflammatory Syndrome
6%
Morbidity
6%
In Vitro
6%
Cytokine
6%
Leishmaniasis
6%
Human Immunodeficiency Virus Infection
6%
Seropositivity
5%
Immunoglobulin M
5%
Booster Dose
5%
Vaginitis
5%
Parasite
5%
Normal Human
5%
Human Immunodeficiency Virus 1
5%
Trypanosoma
5%
Antibody Titer
5%
Ribonucleic Acid
5%
Escherichia coli
5%
Antimicrobial Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
31%
Malaria
29%
Neisseria gonorrhoeae
18%
Artesunate
16%
Tuberculosis
15%
Infection
14%
Artemisinin
13%
Gonorrhea
13%
Rifampicin
12%
Prevalence
11%
Mefloquine
11%
Randomized Controlled Trial
11%
Cohort Study
10%
Diseases
8%
Combination Therapy
8%
Antiinfective Agent
8%
Visceral Leishmaniasis
8%
Artemether Plus Benflumetol
7%
Dihydroartemisinin
7%
Piperaquine
7%
Adverse Event
7%
Antimalarial Agent
6%
Skin Leishmaniasis
6%
Bedaquiline
6%
Schistosomiasis
6%
Placebo
6%
Prednisone
6%
Monotherapy
6%
Chlamydiae
6%
Chlamydia Trachomatis
6%
Hansen's disease
6%
Sodium Stibogluconate
6%
Azithromycin
6%
Praziquantel
5%
Vaccination
5%
Lactobacillus
5%
Retrospective Study
5%